Annual Working Capital
$1.01 B
-$3.08 B-75.26%
December 31, 2024
Summary
- As of February 7, 2025, NVS annual working capital is $1.01 billion, with the most recent change of -$3.08 billion (-75.26%) on December 31, 2024.
- During the last 3 years, NVS annual working capital has fallen by -$14.50 billion (-93.48%).
- NVS annual working capital is now -93.48% below its all-time high of $15.51 billion, reached on December 31, 2021.
Performance
NVS Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Working Capital
$1.01 B
-$2.12 B-67.69%
December 31, 2024
Summary
- As of February 7, 2025, NVS quarterly working capital is $1.01 billion, with the most recent change of -$2.12 billion (-67.69%) on December 31, 2024.
- Over the past year, NVS quarterly working capital has dropped by -$3.08 billion (-75.26%).
- NVS quarterly working capital is now -95.14% below its all-time high of $20.84 billion, reached on June 30, 2010.
Performance
NVS Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
NVS Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -75.3% | -75.3% |
| 3 y3 years | -93.5% | +137.0% |
| 5 y5 years | -18.4% | +137.0% |
NVS Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -93.5% | at low | -93.5% | +135.6% |
| 5 y | 5-year | -93.5% | +129.9% | -93.5% | +112.3% |
| alltime | all time | -93.5% | +129.9% | -95.1% | +112.3% |
Novartis AG Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $1.01 B(-75.3%) | $1.01 B(-67.7%) |
| Sep 2024 | - | $3.13 B(-263.2%) |
| Jun 2024 | - | -$1.92 B(-32.5%) |
| Mar 2024 | - | -$2.84 B(-169.4%) |
| Dec 2023 | $4.09 B(-50.4%) | $4.09 B(-249.7%) |
| Sep 2023 | - | -$2.73 B(-272.5%) |
| Jun 2023 | - | $1.58 B(+1.2%) |
| Mar 2023 | - | $1.56 B(-81.0%) |
| Dec 2022 | $8.25 B(-46.8%) | $8.25 B(-6.1%) |
| Sep 2022 | - | $8.79 B(-16.2%) |
| Jun 2022 | - | $10.50 B(+41.3%) |
| Mar 2022 | - | $7.43 B(-52.1%) |
| Dec 2021 | $15.51 B(-558.1%) | $15.51 B(-527.6%) |
| Sep 2021 | - | -$3.63 B(-37.7%) |
| Jun 2021 | - | -$5.83 B(-26.8%) |
| Mar 2021 | - | -$7.96 B(+135.1%) |
| Dec 2020 | -$3.39 B(-373.1%) | -$3.39 B(+18.2%) |
| Sep 2020 | - | -$2.87 B(-47.9%) |
| Jun 2020 | - | -$5.50 B(-32.9%) |
| Mar 2020 | - | -$8.20 B(-761.0%) |
| Dec 2019 | $1.24 B(-79.2%) | $1.24 B(-180.3%) |
| Sep 2019 | - | -$1.54 B(-13.7%) |
| Jun 2019 | - | -$1.79 B(-51.3%) |
| Mar 2019 | - | -$3.68 B(-161.8%) |
| Dec 2018 | $5.96 B(+24.0%) | $5.96 B(+2.9%) |
| Sep 2018 | - | $5.79 B(+40.4%) |
| Jun 2018 | - | $4.12 B(-14.6%) |
| Mar 2018 | - | $4.83 B(+0.5%) |
| Dec 2017 | $4.80 B(+76.5%) | $4.80 B(+130.2%) |
| Sep 2017 | - | $2.09 B(+432.4%) |
| Jun 2017 | - | $392.00 M(-169.5%) |
| Mar 2017 | - | -$564.00 M(-120.7%) |
| Dec 2016 | $2.72 B(-415.4%) | $2.72 B(+112.8%) |
| Sep 2016 | - | $1.28 B(-150.2%) |
| Jun 2016 | - | -$2.55 B(-47.2%) |
| Mar 2016 | - | -$4.82 B(+459.0%) |
| Dec 2015 | -$863.00 M(-108.2%) | -$863.00 M(-79.0%) |
| Sep 2015 | - | -$4.11 B(-11.4%) |
| Jun 2015 | - | -$4.64 B(+38.9%) |
| Mar 2015 | - | -$3.34 B(-131.6%) |
| Dec 2014 | $10.59 B(+153.7%) | $10.59 B(+4.1%) |
| Sep 2014 | - | $10.17 B(+37.1%) |
| Jun 2014 | - | $7.42 B(+50.5%) |
| Mar 2014 | - | $4.93 B(+18.1%) |
| Dec 2013 | $4.17 B(+5.6%) | $4.17 B(+41.1%) |
| Sep 2013 | - | $2.96 B(+20.4%) |
| Jun 2013 | - | $2.46 B(+476.8%) |
| Mar 2013 | - | $426.00 M(-89.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | $3.95 B(+322.3%) | $3.95 B(-7.8%) |
| Sep 2012 | - | $4.29 B(+256.8%) |
| Jun 2012 | - | $1.20 B(-176.6%) |
| Mar 2012 | - | -$1.57 B(-267.6%) |
| Dec 2011 | $936.00 M(-53.8%) | $936.00 M(-450.6%) |
| Sep 2011 | - | -$267.00 M(-90.8%) |
| Jun 2011 | - | -$2.91 B(-6.7%) |
| Mar 2011 | - | -$3.12 B(-253.7%) |
| Dec 2010 | $2.03 B(-85.7%) | $2.03 B(+3335.6%) |
| Sep 2010 | - | $59.00 M(-99.7%) |
| Jun 2010 | - | $20.84 B(+13.4%) |
| Mar 2010 | - | $18.37 B(+29.2%) |
| Dec 2009 | $14.22 B(+224.9%) | $14.22 B(+13.4%) |
| Sep 2009 | - | $12.54 B(+6.1%) |
| Jun 2009 | - | $11.81 B(+57.7%) |
| Mar 2009 | - | $7.49 B(+71.2%) |
| Dec 2008 | $4.38 B(-59.4%) | $4.38 B(+30.9%) |
| Sep 2008 | - | $3.34 B(-73.0%) |
| Jun 2008 | - | $12.40 B(+34.4%) |
| Mar 2008 | - | $9.23 B(-14.4%) |
| Dec 2007 | $10.79 B(+108.7%) | $10.79 B(-3.5%) |
| Sep 2007 | - | $11.18 B(+140.1%) |
| Jun 2007 | - | $4.66 B(+23.0%) |
| Mar 2007 | - | $3.79 B(-26.8%) |
| Dec 2006 | $5.17 B(-15.5%) | $5.17 B(+11.0%) |
| Sep 2006 | - | $4.66 B(+53.3%) |
| Jun 2006 | - | $3.04 B(-52.0%) |
| Mar 2006 | - | $6.33 B(+3.4%) |
| Dec 2005 | $6.12 B(-49.3%) | $6.12 B(+1.6%) |
| Sep 2005 | - | $6.02 B(-19.4%) |
| Jun 2005 | - | $7.47 B(-31.7%) |
| Mar 2005 | - | $10.94 B(-9.4%) |
| Dec 2004 | $12.07 B(-6.8%) | $12.07 B(-4.0%) |
| Sep 2004 | - | $12.57 B(-0.5%) |
| Jun 2004 | - | $12.64 B(+7.2%) |
| Mar 2004 | - | $11.79 B(-9.0%) |
| Dec 2003 | $12.95 B(+3.3%) | $12.95 B(+6.4%) |
| Sep 2003 | - | $12.17 B(+17.7%) |
| Jun 2003 | - | $10.34 B(-16.2%) |
| Mar 2003 | - | $12.34 B(-1.6%) |
| Dec 2002 | $12.54 B(+4.1%) | $12.54 B(+27.4%) |
| Sep 2002 | - | $9.84 B(-22.1%) |
| Jun 2002 | - | $12.64 B(+4.9%) |
| Dec 2001 | $12.05 B(-8.7%) | $12.05 B(+61.0%) |
| Jun 2001 | - | $7.49 B(-43.3%) |
| Dec 2000 | $13.20 B(+21.7%) | $13.20 B(-7.6%) |
| Jun 2000 | - | $14.29 B |
| Dec 1999 | $10.84 B(-0.3%) | - |
| Dec 1998 | $10.87 B | - |
FAQ
- What is Novartis AG annual working capital?
- What is the all time high annual working capital for Novartis AG?
- What is Novartis AG annual working capital year-on-year change?
- What is Novartis AG quarterly working capital?
- What is the all time high quarterly working capital for Novartis AG?
- What is Novartis AG quarterly working capital year-on-year change?
What is Novartis AG annual working capital?
The current annual working capital of NVS is $1.01 B
What is the all time high annual working capital for Novartis AG?
Novartis AG all-time high annual working capital is $15.51 B
What is Novartis AG annual working capital year-on-year change?
Over the past year, NVS annual working capital has changed by -$3.08 B (-75.26%)
What is Novartis AG quarterly working capital?
The current quarterly working capital of NVS is $1.01 B
What is the all time high quarterly working capital for Novartis AG?
Novartis AG all-time high quarterly working capital is $20.84 B
What is Novartis AG quarterly working capital year-on-year change?
Over the past year, NVS quarterly working capital has changed by -$3.08 B (-75.26%)